Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study
The Journal of Infectious Diseases · 16.06.2026 · 233 (6) · e1433-e1442
DOI: 10.1093/infdis/jiag199 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 02.04.2026. Verfasst von Mitchell A Jeffs und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada. Hauptthemen laut MEDLINE: Cefazolin, Anti-Bacterial Agents, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Department of Medicine, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
It remains unclear if cefazolin inoculum effect (CzIE) translates to poorer clinical outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) infections who were treated with cefazolin.
Methods
This retrospective cohort study across 5 hospitals in Ontario, Canada, from 2021 to 2025 included adult patients who received cefazolin treatment for serious MSSA infection based on blood or deep sterile site culture growth. CzIE was defined as a ≥4-fold increase in cefazolin minimum inhibitory concentration to ≥16 μg/mL at a high inoculum based on broth microdilution assay. Patients were followed to 90 days. Primary outcome was all-cause mortality. Secondary outcome was microbiological treatment failure based on culture growth of MSSA after 1 week of cefazolin treatment. Potential confounders were adjusted using propensity score weighting, and a competing risk model for microbiological treatment failure was used to account for mortality as a competing event.
Results
Of 259 patients, 92 (35.5%) patients had an MSSA isolate that displayed CzIE. The 90-day mortality rate was 19/92 (20.7%) and 37/167 (22.2%) in the CzIE-positive and -negative groups, respectively, with adjusted risk difference of 0.6% (95% CI, −9.0% to 10.2%; P = .9060). Microbiological treatment failure occurred in 19/92 (20.7%) and 10/167 (6.0%) from the CzIE-positive and -negative groups, respectively, with adjusted subdistribution hazard ratio of 3.12 (95% CI, 1.38–7.08; P = .0065) in a competing risk model.
Conclusions
CzIE was associated with a significantly increased risk of microbiological treatment failure. CzIE testing may be useful in guiding antibiotic treatment for serious MSSA infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
- Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
- Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Ontario, Canada.
- Division of Infectious Diseases, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- School of Medicine, Queen's University, Kingston, Ontario, Canada.
ORCID-Profile: Mitchell A Jeffs, Nicole Li, Carson K L Lo, Clayton W Hall, Ameera Nemer, Calvin Ka-Fung Lo, Thuwiba Al Baluki, Zong Heng Shi, Xena X Li, Christopher T Lohans, Anthony D Bai
Förderung
- CIHR
- Department of Medicine
- Canadian Institutes of Health Research
Zitieren
APA
Jeffs, M. A., Li, N., Ogunkoya, O., Duncan, D. B., Lo, C. K. L., Hall, C. W., Nemer, A., Alzarnougi, E., Lo, C. K., Monti, E. B., Al Baluki, T., Shi, Z. H., Li, X. X., Sheth, P. M., Lohans, C. T., & Bai, A. D. (2026). Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study. The Journal of Infectious Diseases, 233(6), e1433-e1442. https://doi.org/10.1093/infdis/jiag199
Vancouver
Jeffs MA, Li N, Ogunkoya O, Duncan DB, Lo CKL, Hall CW, et al. Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study. The Journal of Infectious Diseases. 2026;233(6):e1433-e1442. doi:10.1093/infdis/jiag199
BibTeX
@article{Jeffs2026,
author = {Jeffs, Mitchell A and Li, Nicole and Ogunkoya, Oluwalade and Duncan, D Brody and Lo, Carson K L and Hall, Clayton W and Nemer, Ameera and Alzarnougi, Elaf and Lo, Calvin Ka-Fung and Monti, Emma B and Al Baluki, Thuwiba and Shi, Zong Heng and Li, Xena X and Sheth, Prameet M and Lohans, Christopher T and Bai, Anthony D},
title = {Cefazolin Inoculum Effect and Cefazolin Microbiological Treatment Failure in Serious Methicillin-Susceptible Staphylococcus aureus Infections: A Multicenter Retrospective Cohort Study},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {233},
number = {6},
pages = {e1433--e1442},
doi = {10.1093/infdis/jiag199}
}
EUVIMED